TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20528823

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg/d for 3 days)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ethanol infusion
Number of subjects: 32
Study: 19059570

Group type: EXPERIMENTAL
Intervention: Weekly self-monitoring of INR (group B)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Monthly laboratory monitoring (group A)
Number of subjects: 67
Study: 16629781

Group type: EXPERIMENTAL
Intervention: Ciclesonide 160 microg once daily
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 12860365

Group type: EXPERIMENTAL
Intervention: Intramuscular olanzapine (2.5-10 mg/injection)
Number of subjects: 1251

Group type: COMPARATOR
Intervention: Intramuscular placebo
Number of subjects: 1251

Group type: COMPARATOR
Intervention: Intramuscular haloperidol (7.5 mg/injection)
Number of subjects: 1251

Group type: EXPERIMENTAL
Intervention: Intramuscular olanzapine
Number of subjects: 1251
Study: 11028256

Group type: EXPERIMENTAL
Intervention: terazosin 1, 2, and 5 mg
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: terazosin 2, 5, and 10 mg
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: terazosin 20, 40, and 80 mg
Number of subjects: 128

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 128
Study: 9365347

Group type: EXPERIMENTAL
Intervention: Elbow antagonists reversal exercise
Number of subjects: 28

Group type: COMPARATOR
Intervention: Elbow extension only resistance exercise (control)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control)
Number of subjects: 28
Study: 1550967

Group type: EXPERIMENTAL
Intervention: 0.125% amorolfine cream
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.25% amorolfine cream
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.5% amorolfine cream
Number of subjects: 75

Group type: COMPARATOR
Intervention: 1% bifonazole cream
Number of subjects: 75
Study: 2951798

Group type: EXPERIMENTAL
Intervention: Duovent (fenoterol 100 micrograms and ipratropium bromide 40 micrograms)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 29351487

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Olanzapine with atropine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo with atropine
Number of subjects: 15
Study: 25896101

Group type: EXPERIMENTAL
Intervention: LPS + A (endotoxemia with amino acid supplementation)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: LPS (endotoxemia)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (normal conditions)
Number of subjects: 8
Study: 25247817

Group type: EXPERIMENTAL
Intervention: Low offers by a proposer
Number of subjects: 0
Study: 22419860

Group type: EXPERIMENTAL
Intervention: Iron isomaltoside 1000 (100 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Iron isomaltoside 1000 (200 mg)
Number of subjects: 12
Study: 19032373

Group type: EXPERIMENTAL
Intervention: CoaguChek S or XS POC meter during the PST arm
Number of subjects: 151

Group type: COMPARATOR
Intervention: Routine care by the anticoagulation management service
Number of subjects: 151
Study: 18070440

Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix (ADM)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no ADM)
Number of subjects: 57
Study: 16075412

Group type: EXPERIMENTAL
Intervention: Lisotec (Julphar, UAE)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Zestril (AstraZeneca, UK)
Number of subjects: 28
Study: 10925438

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite cement
Number of subjects: 40

Group type: COMPARATOR
Intervention: Methyl methacrylate implants
Number of subjects: 40
Study: 9313020

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Combined Clonidine and Naltrexone
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 162
Study: 8117550

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 6435

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 6435
Study: 3086991

Group type: EXPERIMENTAL
Intervention: Second first-day endocervical culture
Number of subjects: 748

Group type: EXPERIMENTAL
Intervention: Second-day cultures
Number of subjects: 748

Group type: EXPERIMENTAL
Intervention: Rectal cultures
Number of subjects: 748
Study: 30075711

Group type: EXPERIMENTAL
Intervention: IRIS intervention (Identification and Referral to Improve Safety) implemented in general practices; details on dosage and duration not specified.
Number of subjects: 201

Group type: COMPARATOR
Intervention: Comparator borough (not specified in detail); control group for segmented regression analysis.
Number of subjects: 201
Study: 27382535

Group type: EXPERIMENTAL
Intervention: 0.2% CHX gluconate mouthwash
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 1.5% H2O2 mouthwash
Number of subjects: 45

Group type: COMPARATOR
Intervention: Scaling and root planning (SRP) only
Number of subjects: 45
Study: 23171414

Group type: EXPERIMENTAL
Intervention: Sleep restriction group (4 hours of sleep for 5 nights, then restored to 8 hours for 2 nights)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (8 hours of sleep each night)
Number of subjects: 20
Study: 21247538

Group type: EXPERIMENTAL
Intervention: XIENCE V everolimus‐eluting stent (EES)
Number of subjects: 1002
Study: 17934527

Group type: EXPERIMENTAL
Intervention: Individualized PC-supported training
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Neuropsychological group therapy
Number of subjects: 157

Group type: COMPARATOR
Intervention: No specific training (Control group)
Number of subjects: 157
Study: 16516083

Group type: EXPERIMENTAL
Intervention: rHDL containing low- or high-dose AIM
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 12663588

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (50 ml MgCl(2) solution daily for 16 weeks)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 11149501

Group type: EXPERIMENTAL
Intervention: Reamed intramedullary nailing
Number of subjects: 48

Group type: COMPARATOR
Intervention: Unreamed intramedullary nailing
Number of subjects: 48
Study: 9315990

Group type: EXPERIMENTAL
Intervention: Clonazepam 0.5 mg
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Clonazepam 1.0 mg
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Clonazepam 2.0 mg
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Clonazepam 3.0 mg
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Clonazepam 4.0 mg
Number of subjects: 413

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 413
Study: 8225672

Group type: EXPERIMENTAL
Intervention: Delayed recanalisation of the infarct related artery
Number of subjects: 23

Group type: COMPARATOR
Intervention: Immediate recanalisation of the infarct related artery
Number of subjects: 23

Group type: COMPARATOR
Intervention: Unsuccessful thrombolysis (Group 3)
Number of subjects: 23
Study: 3501763

Group type: EXPERIMENTAL
Intervention: tertatolol 5 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: propranolol 80 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: atenolol 100 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 29778387

Group type: EXPERIMENTAL
Intervention: Maternal antidepressant use (n = 90)
Number of subjects: 3258

Group type: EXPERIMENTAL
Intervention: Currently active major depression (MD) in female partners
Number of subjects: 3258

Group type: EXPERIMENTAL
Intervention: Currently active MD in male partners
Number of subjects: 3258
Study: 27234658

Group type: EXPERIMENTAL
Intervention: Dronabinol 5mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dronabinol 10mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dronabinol 20mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dronabinol 30mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oxycodone 30mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oxycodone 60mg
Number of subjects: 12
Study: 24671634

Group type: EXPERIMENTAL
Intervention: Curved direct contact interface (Group 1)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Modified interface with SoftFit™ (Group 2)
Number of subjects: 200
Study: 23378299

Group type: EXPERIMENTAL
Intervention: Mild renal dysfunction
Number of subjects: 4757

Group type: EXPERIMENTAL
Intervention: Low high-density lipoprotein cholesterol and insulin resistance phenotype
Number of subjects: 4757
Study: 19801149

Group type: EXPERIMENTAL
Intervention: Olmesartan (20 mg)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo + Pravastatin (20 mg)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Co-therapy with Pravastatin
Number of subjects: 190
Study: 18507667

Group type: EXPERIMENTAL
Intervention: Test group 1 (conventional drill preparation with immediate functional loading)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Test group 2 (osteotome technique with immediate functional loading)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group (standard preparation procedure with submerged healing)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Test group 1
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Test group 2
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 151
Study: 20546215

Group type: EXPERIMENTAL
Intervention: ingenol mebutate gel, 0.05% (Arm A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ingenol mebutate gel, 0.0025% or 0.01% (Arm A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: vehicle gel (Arm A and B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ingenol mebutate gel (Arm A)
Number of subjects: 60
Study: 16218171

Group type: EXPERIMENTAL
Intervention: IFN monotherapy (9 MU IFN‐alpha2a three times weekly)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: IFN plus RBV (1000‐1200 mg/day)
Number of subjects: 31
Study: 12377318

Group type: EXPERIMENTAL
Intervention: 70 Gy
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: 78 Gy
Number of subjects: 168

Group type: COMPARATOR
Intervention: Biopsy negative
Number of subjects: 168

Group type: COMPARATOR
Intervention: Biopsy positive
Number of subjects: 168
Study: 9926800

Group type: EXPERIMENTAL
Intervention: Polymerized hemoglobin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Banked blood
Number of subjects: 0
Study: 7821476

Group type: EXPERIMENTAL
Intervention: Operating microscope illumination during cataract surgery
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no cataract surgery)
Number of subjects: 36
Study: 3283172

Group type: EXPERIMENTAL
Intervention: Education with relaxation training
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Education
Number of subjects: 30

Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 30
Study: 29731412

Group type: EXPERIMENTAL
Intervention: Supported Discharge Service (SDS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 0
Study: 26918700

Group type: EXPERIMENTAL
Intervention: Controlled limited formula (10 ml formula by syringe after each breastfeeding, discontinued at onset of lactation)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard approach (SA)
Number of subjects: 104
Study: 24202399

Group type: EXPERIMENTAL
Intervention: Hypokalemia interventions administered pre-admission and post-operative
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (no hypokalemia interventions)
Number of subjects: 118
Study: 22045607

Group type: EXPERIMENTAL
Intervention: Feedback device (Real CPR Help®)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Manikin (Resusci Anne® Advanced SkillTrainer)
Number of subjects: 15
Study: 20693353

Group type: EXPERIMENTAL
Intervention: Aliskiren (150 mg daily titrated to 300 mg daily after 3 months) added to 100 mg losartan
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Aliskiren added to losartan
Number of subjects: 599

Group type: COMPARATOR
Intervention: Placebo added to 100 mg losartan
Number of subjects: 599
Study: 18797706

Group type: EXPERIMENTAL
Intervention: Exercise intervention (6‐12 min cardiovascular activity, 5‐10 min stretching, 15‐30 min resistance training, 8 min cool-down)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 16904417

Group type: EXPERIMENTAL
Intervention: DMPA‐SC 104 (104 mg/0.65 ml subcutaneous injection)
Number of subjects: 2053

Group type: COMPARATOR
Intervention: DMPA‐IM (intramuscular injection)
Number of subjects: 2053
Study: 12534404

Group type: EXPERIMENTAL
Intervention: Etoricoxib (120 mg once daily)
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Ibuprofen (800 mg t.d.s.)
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Naproxen (500 mg b.d.)
Number of subjects: 742

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 742
Study: 10491346

Group type: COMPARATOR
Intervention: Indomethacin (100 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nabumetone (1 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 10
Study: 8902473

Group type: EXPERIMENTAL
Intervention: 25 micrograms salmeterol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 50 micrograms salmeterol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1865943

Group type: EXPERIMENTAL
Intervention: Adhesive zinc oxide tape
Number of subjects: 38

Group type: COMPARATOR
Intervention: Povidone iodine (10%)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Adhesive zinc oxide tape (high activity level)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Adhesive zinc oxide tape (low activity level)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Povidone iodine (10%) (high activity level)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Povidone iodine (10%) (low activity level)
Number of subjects: 38
Study: 7049706

Group type: EXPERIMENTAL
Intervention: Indapamide (2.5 mg daily)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Pindolol (10 mg daily)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Indapamide plus Pindolol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Indapamide
Number of subjects: 16
Study: 29596040

Group type: EXPERIMENTAL
Intervention: Antibiotic agents after I&D
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo after I&D
Number of subjects: 165
Study: 26956032

Group type: EXPERIMENTAL
Intervention: mHealth based dietary intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 24368224

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF) 300 mg
Number of subjects: 280

Group type: COMPARATOR
Intervention: Emtricitabine (FTC) 200 mg + Tenofovir disoproxil fumarate (TDF) 300 mg
Number of subjects: 280
Study: 22327492

Group type: EXPERIMENTAL
Intervention: HPV-16/18 AS04-adjuvanted vaccine (Cervarix)
Number of subjects: 1113
Study: 21200097

Group type: EXPERIMENTAL
Intervention: Ulinastatin 5,000 U/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ulinastatin 10,000 U/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ulinastatin 20,000 U/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 80
Study: 18772704

Group type: EXPERIMENTAL
Intervention: Moderate-dose bifrontal ECT (BF)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Low-dose bitemporal ECT (BT)
Number of subjects: 28
Study: 16319545

Group type: EXPERIMENTAL
Intervention: Long-lasting multifactorial continued educational and behavioural programme (intensive approach)
Number of subjects: 3241

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 3241
Study: 14960663

Group type: EXPERIMENTAL
Intervention: Trapezial excision with ligament reconstruction (group I)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Trapezial excision with ligament reconstruction combined with tendon interposition (group II)
Number of subjects: 43
Study: 10931767

Group type: EXPERIMENTAL
Intervention: Testosterone supplementation in older men
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estrogen supplementation in older women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Testosterone and estrogen effects in men
Number of subjects: 0
Study: 9071516

Group type: EXPERIMENTAL
Intervention: LNG ROD implants
Number of subjects: 398

Group type: COMPARATOR
Intervention: Norplant-2 implants
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 398
Study: 8444762

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Methylphenidate and Desipramine
Number of subjects: 16
Study: 2945123

Group type: EXPERIMENTAL
Intervention: Amitriptyline (75 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Zimelidine (100 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Maprotiline (75 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30285823

Group type: EXPERIMENTAL
Intervention: Web-based education program delivered by teachers
Number of subjects: 1820

Group type: COMPARATOR
Intervention: Control group (no intervention before the program)
Number of subjects: 1820

Group type: EXPERIMENTAL
Intervention: Web-based education program
Number of subjects: 1820

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1820
Study: 27707148

Group type: EXPERIMENTAL
Intervention: Intervention 1 (10-month leadership development program)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Intervention 2 (10-month leadership development program)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Combined effect of both interventions
Number of subjects: 177
Study: 24625200

Group type: EXPERIMENTAL
Intervention: Colistin (1 million IU, n = 73)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo (0.45% saline, n = 71)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Colistin (1 million IU, n = 73) in adherent patients (adherence quartiles 2-4)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo (0.45% saline, n = 71) in adherent patients (adherence quartiles 2-4)
Number of subjects: 144
Study: 22157519

Group type: EXPERIMENTAL
Intervention: Olmesartan 40 mg per day
Number of subjects: 430

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 430
Study: 20023047

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg daily
Number of subjects: 0
Study: 18000167

Group type: EXPERIMENTAL
Intervention: 5-drug induction combination (including idarubicin, fludarabine, interleukin-2)
Number of subjects: 901

Group type: EXPERIMENTAL
Intervention: 5-drug reinduction
Number of subjects: 901

Group type: EXPERIMENTAL
Intervention: Fludarabine/cytarabine/idarubicin
Number of subjects: 901

Group type: COMPARATOR
Intervention: Interleukin-2
Number of subjects: 901

Group type: COMPARATOR
Intervention: Related donor availability
Number of subjects: 901

Group type: COMPARATOR
Intervention: Historical controls
Number of subjects: 901

Group type: COMPARATOR
Intervention: Time period 1996-1998
Number of subjects: 901

Group type: COMPARATOR
Intervention: Time period 2000-2002
Number of subjects: 901

Group type: COMPARATOR
Intervention: Treatment-related mortality
Number of subjects: 901
Study: 15738453

Group type: EXPERIMENTAL
Intervention: Low target blood pressure (mean arterial pressure < 92 mm Hg)
Number of subjects: 840

Group type: COMPARATOR
Intervention: Usual target blood pressure (mean arterial pressure < 107 mm Hg)
Number of subjects: 840
Study: 12533152

Group type: EXPERIMENTAL
Intervention: AlloDerm graft (group 1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No interpositional barrier (group 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Deep-plane rhytidectomy (group 3)
Number of subjects: 30
Study: 10450813

Group type: EXPERIMENTAL
Intervention: Diamond-coated sonic scaler inserts
Number of subjects: 15

Group type: COMPARATOR
Intervention: Hand instruments
Number of subjects: 15
Study: 8705151

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nitroglycerin
Number of subjects: 40
Study: 2368857

Group type: EXPERIMENTAL
Intervention: Smoking cessation after one year
Number of subjects: 12866

Group type: EXPERIMENTAL
Intervention: Smoking cessation for at least three years
Number of subjects: 12866

Group type: COMPARATOR
Intervention: Smoking (current smokers)
Number of subjects: 12866

Group type: EXPERIMENTAL
Intervention: Smoking cessation (quitters)
Number of subjects: 12866
Study: 98128

Group type: EXPERIMENTAL
Intervention: 4 mg protirelin per day for 14 days
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study: 29255885

Group type: EXPERIMENTAL
Intervention: Bilateral low-frequency (20 Hz) NBM DBS
Number of subjects: 6

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 6

Group type: COMPARATOR
Intervention: Preoperative baseline
Number of subjects: 6
Study: 27036394

Group type: EXPERIMENTAL
Intervention: Extended-release niacin (ERN) plus simvastatin/ezetimibe
Number of subjects: 3414

Group type: COMPARATOR
Intervention: Simvastatin/ezetimibe plus placebo
Number of subjects: 3414
Study: 25271149

Group type: EXPERIMENTAL
Intervention: Traditional acupuncture
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Minimal acupuncture
Number of subjects: 150

Group type: COMPARATOR
Intervention: Non-invasive sham acupuncture
Number of subjects: 150
Study: 22865313

Group type: EXPERIMENTAL
Intervention: Transradial catheterization (TRI)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Transfemoral catheterization (TFI)
Number of subjects: 119
Study: 20538217

Group type: EXPERIMENTAL
Intervention: Greek traditional dances (1 hour)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group (discussion and watching television for 1 hour)
Number of subjects: 111
Study: 18503578

Group type: EXPERIMENTAL
Intervention: Integrated approach of yoga therapy (IAYT)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (simple physical exercises)
Number of subjects: 108